Clinical TrialsSearch results
Number of results: 205
Other
- An Open-Label Randomized Phase III Study of Capecitabine(6 months) versus Capecitabine(12 months) as Adjuvant Chemotherapy for Stage III(Dukes'C) Colon Cancer Patients.
- Colon cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2008-09-10
Other
- An exploratory research for a case with peripheral artery disease as a complication of lumbar spinal canal stenosis.
- lumbar spinal canal stenosis
- Fukushima medical university school of medicine
- 2008-12-05
Other
- Allogeneic stem cell transplantation following reduced-intensity conditioning for relapsed/refractory peripheral T-cell non-Hodgkin's lymphomas
- relapsed/refractory peripheral T-cell non-Hodgkin's lymphomas
- West Japan Hematology Oncology Group/ Hematological Malignancy Therapy Study Group/ Japan Study Group for Cell Therapy and Transplantation
- 2008-11-07
Other
- Additional JET Study for Patients during Maintenance Phase(Co-JET Study)
- maintenance-phase renal failure (predialysis renal failure)
- Scientific Advisory Committee (SAC)
- 2005-10-01
Other
- A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
- Ulcerative colitis or Crohn's Disease
- Yamasaki Fumie
- 2022-10-21
Recruiting
- A study to test long-term safety of BI 425809 in people with schizophrenia who took part in a previous CONNEX study
- schizophrenia
- Suzuki Yu
- 2022-06-10
Other
- A study to observe correlation between resection and reconstruction procedures employed for gastric neoplasms and development of postgastrectomy syndrome
- Gastric cancer patients who underwent various types of gastrectomy (GIST patients who underwent gastric wedge resection are also included)
- Department of Surgery, The Jikei University School of Medicine
- 2009-06-25
Recruiting
- A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
- Ulcerative colitis or Crohn's Disease
- Yamasaki Fumie
- 2023-04-11
Recruiting
- A study to evaluate the efficacy and safety of subcutaneous amlitelimab on background topical corticosteroids therapy in participants aged 12 years and older with moderate-to-severe AD who have had an inadequate response to prior biologic therapy or an oral JAK inhibitor
- Dermatitis atopic
- Tanaka Tomoyuki
- 2024-05-08
Recruiting
- A study to evaluate the efficacy and safety of subcutaneous amlitelimab monotherapy compared with placebo in participants aged 18 years and older with moderate-to-severe atopic dermatitis
- Dermatitis atopic
- Tanaka Tomoyuki
- 2024-01-13